Notice Title

Consent to the Distribution of New Medicines

Publication Date
20 Mar 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go1483
Title
View PDF
File Type and Size
PDF (40 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Demazin 12 Hour
Nasal Decongestant Spray
Active Ingredient: Oxymetazoline hydrochloride 0.5mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: Noumed Pharmaceuticals Limited
Manufacturer: Probiotec Pharma Pty Limited, Melbourne, Australia
   
Product: Demazin Cold + Flu Relief
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Noumed Pharmaceuticals Limited
Manufacturer: Probiotec Pharma Pty Limited, Melbourne, Australia
   
Product: Lyrica
Active Ingredient: Pregabalin 25mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico Strides Pharma Science Limited, Puducherry, India
   
Product: Lyrica
Active Ingredient: Pregabalin 75mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany
Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Strides Pharma Science Limited, Puducherry, India
   
Product: Lyrica
Active Ingredient: Pregabalin 150mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany
Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Strides Pharma Science Limited, Puducherry, India
   
Product: Lyrica
Active Ingredient: Pregabalin 300mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany
Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Strides Pharma Science Limited, Puducherry, India
   
Product: Trikafta 100/50/75
Component 1:  
Active Ingredients: Elexacaftor 100mg
Ivacaftor 75mg
Tezacaftor 50mg
Dosage Form: Film coated tablet
Component 2:  
Active Ingredient: Ivacaftor 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Vertex Pharmaceutical Incorporated, Massachusetts, United States of America
Aesica Queenborough Limited, Kent, United Kingdom
Patheon Pharmaceuticals Inc, Ohio, United States of America
   
Product: Trikafta 50/25/37.5
Component 1:  
Active Ingredients: Elexacaftor 50mg
Ivacaftor 37.5mg
Tezacaftor 25mg
Dosage Form: Film coated tablet
Component 2:  
Active Ingredient: Ivacaftor 75mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Vertex Pharmaceutical Incorporated, Massachusetts, United States of America
Patheon Pharmaceuticals Inc, Ohio, United States of America


Dated this 14th day of March 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).